We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Corporate Giving

We strive to improve the health and wellbeing of all patients, and create a future of science that is more diverse, inclusive and equitable. Our giving reflects this vision, and supports schools, community-based organizations, patient groups and scientific and medical communities to help uncover and deliver solutions that ensure a healthier future for everyone.

We’re also addressing systemic inequities in our society through partnerships with a wide range of organizations that focus on the issues facing our communities, from inequities in health and education to racial injustice.

Important Notices

Temporary Year-end Closure

Due to our 2021 year-end close process, the Genentech Funding Request System will stop accepting Fellowship, Scientific Project, Healthcare-Related and Philanthropic Charitable Support requests at 12:00AM PT, Wednesday, November 24 and will reopen for requests on Monday, January 3, 2022.

This temporary closure affects Healthcare-Related Charitable support, Scientific Project Support, Fellowship and Philanthropic Support requests. Independent Medical Education will continue to be accepted during this time.

It is important to note the Genentech Funding Request System cannot accept requests less than 60 days prior to the event/program start date. Therefore, if you plan to submit a charitable contribution request for an event or program occurring before March 4, 2022, please submit your request no later than November 23, to ensure consideration.

Pending requests with event/program dates beginning in January 2022 or beyond may receive final decisions in the new year.


Update on Funding Opportunities

Genentech is committed to advancing health equity, supporting diversity in STEM and medical career pathways, supporting patients, scientific exchange, and our local communities.

While we remain committed to these values and funding priorities, we are no longer accepting unsolicited grant submissions for the 2021 funding year with the exception of Independent Medical Education (IME) submissions. We invite you to periodically review our website for future funding opportunities.

If you have been invited to apply for funding, or are an existing grantee with specific questions about current funding and reporting, please reach out to your Genentech contact to address your questions. If you are unsure of who to contact with questions, please email [email protected] and you will be directed to the appropriate contact.


COVID-19 Impact on Grant Programs & Events

Genentech is committed to supporting our existing grantees during the evolving coronavirus (COVID-19) pandemic. We understand that grantees will have their own challenges in adapting to rapidly changing events, and we will work to accommodate needs for the programs funded by Genentech.

If you are an existing grantee, please contact your Genentech representative with questions or to let us know if your program or event will be cancelled or postponed. If you are unsure of who to contact, please email [email protected] and we will direct you to the appropriate person.

To learn more about Genentech’s efforts during the pandemic, please visit our COVID-19 response page.


We develop deep partnerships with organizations that are committed to solving problems, delivering measurable results and continuing to improve upon their efforts. Beyond grants, we often offer pro bono expertise and volunteer support to our partners.

Our charitable giving strategy focuses on three areas:

1. A Diverse Future of STEM: Education to Employment

We are committed to the long-term efforts required to build a more diverse and inclusive science and healthcare workforce.

From education to employment, we create pathways into the life sciences for underrepresented groups, particularly low-income students of color. We support all stages of these career pathways—from inspiring and building confidence in elementary and middle school students through hands-on science, to increasing access to industry-aligned career exploration learning in high school, to providing postsecondary students with financial, academic and career building support and awarding research grants for early and mid-career professionals.

We also support ongoing education and collaboration among the scientific and medical communities through grants for scientific meetings and fellowships for advanced study by clinical and research professionals.

Learn more about:

If you are an organization in the Bay Area seeking a grant related to K-12 STEM education, please contact [email protected] before submitting a grant request.

2. Health Equity

We’re tackling the biggest barriers to equitable healthcare for all patients by addressing root causes of existing disparities and driving toward a more fair and just healthcare system. We help build a foundation of health for young children and their families by interrupting the impacts of stress and trauma. We also reduce barriers to participation in clinical trials so healthcare solutions are designed for all patients. And we close gaps in health outcomes by ensuring all patients have access to high quality care, including early detection and diagnosis, comprehensive education, support services and medicine.

Learn more about:

3. Vibrant Communities

We partner with local organizations to address critical issues relevant to the communities where Genentech is located. This includes funding for food banks, emergency shelters and afterschool programs, as well as investments in innovative approaches to addressing the Bay Area's housing crisis.

Learn more about:

Independent Medical Education

We also further advance excellence in medicine and healthcare through our grants for independent medical education. Learn more about our grants for independent medical education for healthcare providers.


Note: The funding application site does not support IE8 or earlier

*We are no longer accepting unsolicited grant submissions for the 2021 funding year.

*We are no longer accepting unsolicited grant submissions for the 2021 funding year.